Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
出版年份 2015 全文链接
标题
Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
作者
关键词
Osteosarcoma, Multidrug resistance mechanisms, Reversal
出版物
TUMOR BIOLOGY
Volume 36, Issue 3, Pages 1329-1338
出版商
Springer Nature
发表日期
2015-02-10
DOI
10.1007/s13277-015-3181-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
- (2015) Michela Pasello et al. Analytical Cellular Pathology
- Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
- (2014) X Yang et al. BRITISH JOURNAL OF CANCER
- mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels
- (2014) Kaveh M Goudarzi et al. CANCER BIOLOGY & THERAPY
- Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy
- (2014) J.Z. Li et al. GENETICS AND MOLECULAR RESEARCH
- Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma
- (2014) Haoshaqiang Zhang et al. HUMAN PATHOLOGY
- Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models
- (2014) Emmy D.G. Fleuren et al. INTERNATIONAL JOURNAL OF CANCER
- miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
- (2014) Yong Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival
- (2014) Jilong Yang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- ERCC polymorphisms and prognosis of patients with osteosarcoma
- (2014) Jinsong Li et al. TUMOR BIOLOGY
- High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy
- (2014) Chaoqun Yang et al. TUMOR BIOLOGY
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Glutathione S-transferase P1 and DNA Polymorphisms with the Response to Chemotherapy and the Prognosis of Bone Tumor
- (2013) Li-Min Yang et al. Asian Pacific Journal of Cancer Prevention
- Association of Four ERCC1 and ERCC2 SNPs with Survival of Bone Tumour Patients
- (2013) Ting Hao et al. Asian Pacific Journal of Cancer Prevention
- The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
- (2013) Zeze Fu et al. BMC CANCER
- VEGFR, RET, and RAF/MEK/ERK Pathway Take Part in the Inhibition of Osteosarcoma MG63 Cells with Sorafenib Treatment
- (2013) Jiong Mei et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The P-Glycoprotein Transport System and Cardiovascular Drugs
- (2013) Jeffrey D. Wessler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A systematic review of p53 as a biomarker of survival in patients with osteosarcoma
- (2013) Hai-Liang Fu et al. TUMOR BIOLOGY
- Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse
- (2013) Aurelia Nguyen et al. Cancers
- Increased expression and function of P-glycoprotein in peripheral blood CD56+ cells is associated with the chemoresistance of non-small-cell lung cancer
- (2012) Li Han et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways
- (2012) Ching-Lung Liao et al. FOOD AND CHEMICAL TOXICOLOGY
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
- (2011) Rachael E. Windsor et al. CANCER
- Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients
- (2011) Xing Wu et al. Cancer Epidemiology
- Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
- (2011) Amit K. Tiwari et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma
- (2011) Daria Brambilla et al. INTERNATIONAL JOURNAL OF CANCER
- Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma
- (2011) Santosh S. Dhule et al. Nanomedicine-Nanotechnology Biology and Medicine
- Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
- (2011) G Bulut et al. ONCOGENE
- Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy
- (2011) P Biason et al. PHARMACOGENOMICS JOURNAL
- Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models
- (2010) J Rousseau et al. CANCER GENE THERAPY
- CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance
- (2010) Amit S. Adhikari et al. CANCER RESEARCH
- Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process
- (2010) G. Moriceau et al. CANCER RESEARCH
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
- (2010) Bo Song et al. Molecular Cancer
- Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
- (2010) Michiro Susa et al. PLoS One
- Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells
- (2010) S.-H. Hong et al. Veterinary and Comparative Oncology
- The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis
- (2009) Harzem Ozger Acta Orthopaedica et Traumatologica Turcica
- Multiple pathways are involved in drug resistance to doxorubicin in an osteosarcoma cell line
- (2009) Thangarajan Rajkumar et al. ANTI-CANCER DRUGS
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
- (2009) Sudan He et al. CELL
- Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
- (2009) Rosaria Gangemi et al. CURRENT MEDICINAL CHEMISTRY
- Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment
- (2009) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression
- (2009) Ana Patiño-García et al. JOURNAL OF PEDIATRICS
- Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
- (2009) Ymera Pignochino et al. Molecular Cancer
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
- Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents
- (2009) Sharada D. Vangipuram et al. PEDIATRIC BLOOD & CANCER
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
- (2009) D.-W. Zhang et al. SCIENCE
- Overcoming Glutathione S-Transferase P1-Related Cisplatin Resistance in Osteosarcoma
- (2008) M. Pasello et al. CANCER RESEARCH
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
- Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours
- (2008) Virginia Tirino et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started